title: Sister chromatid cohesion defects are associated with chromosome instability in Hodgkin lymphoma cells.
abstract: BACKGROUND
  Chromosome instability manifests as an abnormal chromosome complement and is a pathogenic event in cancer. Although a correlation between abnormal chromosome numbers and cancer exist, the underlying mechanisms that cause chromosome instability are poorly understood. Recent data suggests that aberrant sister chromatid cohesion causes chromosome instability and thus contributes to the development of cancer. Cohesion normally functions by tethering nascently synthesized chromatids together to prevent premature segregation and thus chromosome instability. Although the prevalence of aberrant cohesion has been reported for some solid tumors, its prevalence within liquid tumors is unknown. Consequently, the current study was undertaken to evaluate aberrant cohesion within Hodgkin lymphoma, a lymphoid malignancy that frequently exhibits chromosome instability.
  
  
  METHODS
  Using established cytogenetic techniques, the prevalence of chromosome instability and aberrant cohesion was examined within mitotic spreads generated from five commonly employed Hodgkin lymphoma cell lines (L-1236, KM-H2, L-428, L-540 and HDLM-2) and a lymphocyte control. Indirect immunofluorescence and Western blot analyses were performed to evaluate the localization and expression of six critical proteins involved in the regulation of sister chromatid cohesion.
  
  
  RESULTS
  We first confirmed that all five Hodgkin lymphoma cell lines exhibited chromosome instability relative to the lymphocyte control. We then determined that each Hodgkin lymphoma cell line exhibited cohesion defects that were subsequently classified into mild, moderate or severe categories. Surprisingly, ~50% of the mitotic spreads generated from L-540 and HDLM-2 harbored cohesion defects. To gain mechanistic insight into the underlying cause of the aberrant cohesion we examined the localization and expression of six critical proteins involved in cohesion. Although all proteins produced the expected nuclear localization pattern, striking differences in RAD21 expression was observed: RAD21 expression was lowest in L-540 and highest within HDLM-2.
  
  
  CONCLUSIONS
  We conclude that aberrant cohesion is a common feature of all five Hodgkin lymphoma cell lines evaluated. We further conclude that aberrant RAD21 expression is a strong candidate to underlie aberrant cohesion, chromosome instability and contribute to the development of the disease. Our findings support a growing body of evidence suggesting that cohesion defects and aberrant RAD21 expression are pathogenic events that contribute to tumor development.
authors: Manitoba Institute of Cell Biology and the Department of Biochemistry & Medical Genetics, University of Manitoba, ON6010 - 675 McDermot Avenue, Winnipeg, Manitoba MB R3E 0V9, Canada.
authors: Babu V
authors: BV
authors: Sajesh
authors: Zelda
authors: Z
authors: Lichtensztejn
authors: Kirk J
authors: KJ
authors: McManus
mesh_terms: D045744:Cell Line, Tumor; D002842:Chromatids / Q000235:genetics* / Q000473:pathology; D043171:Chromosomal Instability / Q000235:genetics*; D020090:Chromosome Segregation / Q000235:genetics*; D019084:Fluorescent Antibody Technique, Indirect; D006689:Hodgkin Disease / Q000235:genetics* / Q000473:pathology; D006801:Humans; D015151:Immunoblotting
references: Nature. 2011 Jun 29;474(7353):609-15
references: 21720365
references: Breast Cancer Res Treat. 2011 Sep;129(2):617-22
references: 21607584
references: EMBO J. 2012 May 2;31(9):2076-89
references: 22415365
references: Blood. 1989 Jun;73(8):2149-54
references: 2730953
references: Cell. 2001 May 18;105(4):445-57
references: 11371342
references: Cell Cycle. 2012 Jun 15;11(12):2233-8
references: 22617390
references: Nature. 1998 Mar 19;392(6673):300-3
references: 9521327
references: Nat Genet. 2010 Aug;42(8):715-21
references: 20601955
references: Nature. 2012 Sep 27;489(7417):519-25
references: 22960745
references: Virchows Arch. 2006 Apr;448(4):435-41
references: 16416296
references: J Natl Cancer Inst. 1992 Dec 2;84(23):1789-93
references: 1433367
references: Science. 2011 Aug 19;333(6045):1039-43
references: 21852505
references: J Pathol. 1999 Jun;188(2):139-45
references: 10398156
references: Leukemia. 2009 Mar;23(3):565-73
references: 19039323
references: Nature. 2012 Mar 28;483(7391):603-7
references: 22460905
references: Genes Chromosomes Cancer. 2004 Jan;39(1):1-10
references: 14603436
references: Ann Hematol. 2003 Aug;82(8):492-495
references: 12910376
references: Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3443-8
references: 18299561
references: Mol Cell Biol. 2003 Nov;23(21):7611-27
references: 14560007
references: Cell. 2012 Jul 20;150(2):264-78
references: 22817890
references: Haematologica. 2010 Dec;95(12):2038-46
references: 20823137
references: Nat Cell Biol. 2011 Oct 03;13(10):1170-7
references: 21968990
references: Genes Chromosomes Cancer. 1992 Nov;5(4):392-8
references: 1283328
references: Nature. 2012 Oct 4;490(7418):61-70
references: 23000897
references: Trends Genet. 2012 Jul;28(7):351-60
references: 22542109
references: Nat Med. 2004 Aug;10(8):789-99
references: 15286780
references: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11283-8
references: 11553793
references: Breast Cancer Res. 2011 Jan 21;13(1):R9
references: 21255398
references: Leukemia. 2000 Oct;14(10):1803-14
references: 11021756
references: Clin Genet. 2009 Oct;76(4):303-14
references: 19793304
references: Chromosoma. 2007 Feb;116(1):1-13
references: 16819604
references: Cancer Res. 2004 May 1;64(9):2998-3001
references: 15126332
references: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14295-300
references: 11121035
references: Exp Cell Res. 2010 May 15;316(9):1445-53
references: 20043905
references: Chromosoma. 2007 Aug;116(4):321-9
references: 17333234
references: Am J Hematol. 2010 Sep;85(9):717-9
references: 20687102
references: Mol Cancer Ther. 2005 Mar;4(3):361-8
references: 15767545
references: Nature. 2004 Mar 4;428(6978):77-81
references: 14999283
references: Genes Chromosomes Cancer. 2011 Dec;50(12):996-1009
references: 21987443
references: Virchows Arch A Pathol Anat Histopathol. 1988;413(5):463-8
references: 2845644
references: Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3276-81
references: 19218431
references: Cancer Res. 1983 Jun;43(6):2975-84
references: 6850608
references: Nat Genet. 2006 Sep;38(9):1043-8
references: 16921376
references: Nature. 2012 Jul 18;487(7407):330-7
references: 22810696
references: Crit Rev Oncol Hematol. 2009 Dec;72(3):181-93
references: 19162508
references: PLoS One. 2013 Jun 03;8(6):e63313
references: 23755103
references: Cancer Biol Ther. 2002 Nov-Dec;1(6):685-92
references: 12642695
references: J Cell Sci. 2008 Jan;121 Suppl 1:v-vi
references: 18089651
references: J Cancer Res Clin Oncol. 1981;101(1):111-24
references: 7276066
references: Oncol Lett. 2012 Oct;4(4):727-732
references: 23205091
references: Methods. 2005 Aug;36(4):351-61
references: 16095916
references: Mol Biol Cell. 2005 Aug;16(8):3908-18
references: 15958495